
usd feb pm et
summari develop manufactur distribut product servic companion anim
veterinari livestock poultri water test dairi market world-wide
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
pm stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
rais target
above-p ep estim
think multipl appropri given
attract growth opportun robust
recur revenu ep vs
higher estim lower
ep estim
initi ep estim
revenu increas yoy organ
segment sale led way
yoy growth revenu organ
sale continu benefit expand
premium instrument base benefit
diagnost consult servic also saw
robust growth quarter organ sale
growth yoy sale total
continu domin growth increas
yoy versu growth intern sale
despit attract growth opportun
think share current near fair
see demand product servic
remain strong pet ownership increas global
consum spend pet-rel servic
could lose market share competitor face
increas price pressur think
maintain net debt ebitda
ratio recent year
concern macroeconom downturn think
could pressur given product
servic tie discretionari consum spend
fiscal year end dec ep estim base cfra
oper earn histor earn report
cash dividend paid last year
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview inc togeth subsidiari develop manufactur
distribut product servic primarili companion anim veterinari livestock poultri
water test dairi market world-wide compani provid point-of-car veterinari diagnost
product includ instrument consum rapid assay veterinari refer laboratori
diagnost consult servic practic manag system servic digit imag
system veterinarian biolog materi test laboratori anim diagnost instrument
servic biomed research commun also offer diagnost health-monitor food
safeti test product livestock poultri dairi market product test water variou
microbiolog contamin point-of-car electrolyt blood ga analyz use
oper three primari busi segment companion anim group water qualiti
product livestock poultri dairi oper segment contain busi
meet quantit threshold report segment
companion anim group total sale provid veterinarian diagnost capabl
inform manag solut enhanc health well-b pet diagnost
provid diagnost capabl meet veterinarian divers need varieti modal
includ in-clin diagnost solut outsid refer laboratori servic in-clin diagnost
solut compris vetlab suit in-clin chemistri hematolog immunoassay
urinalysi coagul analyz associ proprietari consum product provid real-tim
refer lab qualiti diagnost result broad rang single-us handheld snap rapid assay
test kit provid quick accur conveni point-of-car diagnost test result varieti
companion anim diseas health condit offer commerci refer laboratori diagnost
consult servic veterinarian world-wide compani refer laboratori offer larg
select test diagnost panel detect number diseas state condit
anim includ test run in-clin veterinari practic instrument rapid
assay diagnost imag system captur radiograph imag digit form replac
tradit x-ray film film develop process gener requir use hazard
chemic darkroom
water qualiti product segment provid innov test solut easi rapid
accur detect quantif variou microbiolog paramet water princip
product colilert colisur test simultan detect presenc total
coliform coli water compani water test use govern laboratori water
util privat certifi laboratori test drink water complianc regulatori standard
includ environment protect agenc standard test also use evalu water
use product process exampl beverag pharmaceut applic
evalu bottl water recreat water wastewat water privat well
livestock poultri dairi segment sell diagnost test servic relat
instrument use manag health statu livestock poultri improv bovin
reproduct effici ensur qualiti safeti milk food livestock poultri
diagnost product purchas govern privat laboratori provid test servic
livestock veterinarian produc processor princip livestock poultri diagnost product
includ test bovin viral diarrhea viru porcin reproduct respiratori syndrom
segment sell point-of-car analyz relat consum use human
medic hospit clinic measur electrolyt blood gase acid-bas balanc glucos lactat
blood urea nitrogen ioniz calcium calcul paramet base excess anion
gap opti analyz use primarili emerg room oper room cardiac monitor
area locat time-crit diagnost test perform within hospit set
market profil compet mani compani rang larg human pharmaceut
medic diagnost compani small busi focus anim health companion anim
group primari north american competitor includ antech diagnost unit vca inc abaxi inc
heska corpor zoeti inc electrolyt blood ga analyz market compet
primarili larg human medic diagnost compani radiomet a/ siemen medic
solut diagnost instrument laboratori compani abbott diagnost divis abbott
laboratori roch diagnost corpor
financi experienc revenu growth follow growth
five-year compound annual growth rate revenu total cash short-term
invest stood million end total debt billion
world-wide oper
senior director
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu usd
bullish sinc januari technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
industri
possibl threat state health
care system lawsuit texa
rule unconstitut
current expect upheld upon
appeal although decis could take
coupl year reach democrat
take control hous
repres think see
significantli lower level effort
republican trump administr
tri repeal
hospit spend larg driver medic
equip sale robust
strong economi
tax cut job act tcja individu
mandat roll think
hospit could see pressur lead
sale pressur medic equip
requir american health
insur without requir
expect lower number american
gener see posit long-term
fundament includ increas global
demand qualiti health care age
popul rise outlay lead
steadi flow innov product
 health equip
sub-index rose vs declin
fundament outlook health care
equip sub-industri next month
neutral slightli posit continu
expect compani sub-industri
grow posit macro environ
compani gener benefit
laxer food drug administr fda
technolog advanc sub-industri
also mani product area
equip use non-elect procedur
howev valuat high industri
investor sentiment medic devic
compani appear shaken
volatil late think
higher valuat sub-industri
mostli warrant recent expand
margin robust revenu growth weaker
constant currenc basi expect
revenu sub-industri continu
rise high-single-digit low-double-digit
percentag driven continu pipelin
innov new product emerg market
expans speed new product
come market increas recent
year success effort
fda reduc approv time medic
devic time see price
pressur incess headwind medic
impact trade war appear mild
far medic equip compani
accord medic devic trade
tariff billion medic
technolog export septemb
although chines
govern seek lower health care cost
equip manufactur insul
base index
five-year market price perform feb
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
last five year ep vs higher
estim rais ep ep
sale increas organ million driven
growth organ companion anim group busi
sale idxx latest product sdma test kidney function gener
avail first full quarter saw adopt north american
catalyst diagnost tool custom see import driver futur
revenu growth although impress idxx innov increas
sale exist custom think stock overvalu base price-to-earnings
multipl discount cash flow dcf basi /kevin huang
laboratori keep target
ep estim compar ten-year forward averag price-to-earnings
reflect stabl sale growth outlook rais ep
estim mostli driven tax reform set
estim report oper ep
vs consensu sale increas growth
segment driven growth vetlab consum expect
sale growth driven steadi growth refer laboratori
diagnost consult servic /keith snyder
laboratori inc rais target
ep estim premium peer line
three-year forward averag price-to-earnings reflect stabl organ sale growth
improv margin level driven increas recur revenu rais
ep estim
report oper ep vs consensu
sale increas driven growth segment see
sale growth strong recur revenu growth addit
analyst research note compani news
pm et cfra maintain hold opinion share
inc rais target
above-p ep estim think multipl appropri
given attract growth opportun robust recur revenu
ep vs higher estim lower
ep estim initi ep estim
revenu increas yoy organ million companion
anim group segment sale led way yoy growth
revenu organ sale continu benefit expand premium
instrument base benefit new test innov refer laboratori
diagnost consult servic also saw robust growth quarter
organ sale growth yoy sale total continu
domin growth increas yoy versu growth intern sale
despit attract growth opportun think share current
hold sell rais target
above-p ep estim think
multipl appropri given growth opportun recur
revenu ep vs higher estim
lower ep sale increas organ
million sale largest busi companion anim
group grew organ announc revenu growth
outlook rang organ
expand instal global base catalyst chemistri analyz
refer lab diagnost consult servic part growth abroad
weaker expect due unfavor weather condit europ
constrain visit downward stock price correct octob
find trade much closer fair valu rais
opinion hold /kevin huang cfa
laboratori rais target
above-p ep estim ep
vs higher estim rais ep
ep sale increas
organ million sale largest busi companion
effort intern transit sale structur
customer-centr direct model similar one drive
sale growth north america intend augment
intern invest drive increment revenu margin
downsid reduc full-year revenu guidanc continu
think expect high share trade
intrins valu /kevin huang cfa
et cfra maintain sell rate share
abax nr announc today acquir zoeti
lead anim health compani billion reaffirm
previous highlight concern anim diagnost industri could
becom increasingli competit given attract press releas
highlight acquisit abax support strategi deploy
capit high-growth segment animal-health industri think
sizeabl global reach greater financi flexibl enabl
combin entiti chip away domin share companion anim
diagnost market share significantli today follow news
zts/abax deal /kevin huang cfa
laboratori inc rais target
above-p idxx averag forward pe
ep estim idxx forward pe rang
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
